These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 26819256)

  • 1. Effect of Induced Pluripotent Stem Cell Technology in Blood Banking.
    Focosi D; Pistello M
    Stem Cells Transl Med; 2016 Mar; 5(3):269-74. PubMed ID: 26819256
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Can cord blood banks transform into induced pluripotent stem cell banks?
    Zhou H; Rao MS
    Cytotherapy; 2015 Jun; 17(6):756-764. PubMed ID: 25770678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioengineering: Doing without donors.
    Dolgin E
    Nature; 2017 Sep; 549(7673):S12-S15. PubMed ID: 28953861
    [No Abstract]   [Full Text] [Related]  

  • 4. Banking of pluripotent adult stem cells as an unlimited source for red blood cell production: potential applications for alloimmunized patients and rare blood challenges.
    Peyrard T; Bardiaux L; Krause C; Kobari L; Lapillonne H; Andreu G; Douay L
    Transfus Med Rev; 2011 Jul; 25(3):206-16. PubMed ID: 21377319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Report of the International Stem Cell Banking Initiative Workshop Activity: Current Hurdles and Progress in Seed-Stock Banking of Human Pluripotent Stem Cells.
    Kim JH; Kurtz A; Yuan BZ; Zeng F; Lomax G; Loring JF; Crook J; Ju JH; Clarke L; Inamdar MS; Pera M; Firpo MT; Sheldon M; Rahman N; O'Shea O; Pranke P; Zhou Q; Isasi R; Rungsiwiwut R; Kawamata S; Oh S; Ludwig T; Masui T; Novak TJ; Takahashi T; Fujibuchi W; Koo SK; Stacey GN
    Stem Cells Transl Med; 2017 Nov; 6(11):1956-1962. PubMed ID: 29067781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Artificial Blood Substitutes: First Steps on the Long Route to Clinical Utility.
    Moradi S; Jahanian-Najafabadi A; Roudkenar MH
    Clin Med Insights Blood Disord; 2016; 9():33-41. PubMed ID: 27812292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of human leukocyte antigen matching in the development of multiethnic "haplobank" of induced pluripotent stem cell lines.
    Gourraud PA; Gilson L; Girard M; Peschanski M
    Stem Cells; 2012 Feb; 30(2):180-6. PubMed ID: 22045598
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concise review: Cord blood banking, transplantation and induced pluripotent stem cell: success and opportunities.
    Rao M; Ahrlund-Richter L; Kaufman DS
    Stem Cells; 2012 Jan; 30(1):55-60. PubMed ID: 22069231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Will iPS cells enhance therapeutic applicability of cord blood cells and banking?
    Broxmeyer HE
    Cell Stem Cell; 2010 Jan; 6(1):21-4. PubMed ID: 20074533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tissue engineering red blood cells: a therapeutic.
    van Veen T; Hunt JA
    J Tissue Eng Regen Med; 2015 Jul; 9(7):760-70. PubMed ID: 24753354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Umbilical cord blood as a source of stem cells].
    Bojanić I; Golubić Cepulić B
    Acta Med Croatica; 2006 Jun; 60(3):215-25. PubMed ID: 16933834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Umbilical cord blood donation: public or private?
    Ballen KK; Verter F; Kurtzberg J
    Bone Marrow Transplant; 2015 Oct; 50(10):1271-8. PubMed ID: 26030051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Banking on Blood.
    EBioMedicine; 2016 Jun; 8():1-2. PubMed ID: 27428400
    [No Abstract]   [Full Text] [Related]  

  • 14. Red blood cells from induced pluripotent stem cells: hurdles and developments.
    Mazurier C; Douay L; Lapillonne H
    Curr Opin Hematol; 2011 Jul; 18(4):249-53. PubMed ID: 21519239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Report from a Workshop of the International Stem Cell Banking Initiative, Held in Collaboration of Global Alliance for iPSC Therapies and the Harvard Stem Cell Institute, Boston, 2017.
    Kim JH; Alderton A; Crook JM; Benvenisty N; Brandsten C; Firpo M; Harrison PW; Kawamata S; Kawase E; Kurtz A; Loring JF; Ludwig T; Man J; Mountford JC; Turner ML; Oh S; da Veiga Pereira L; Pranke P; Sheldon M; Steeg R; Sullivan S; Yaffe M; Zhou Q; Stacey GN
    Stem Cells; 2019 Sep; 37(9):1130-1135. PubMed ID: 31021472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cord blood banking: a historical perspective.
    Navarrete C; Contreras M
    Br J Haematol; 2009 Oct; 147(2):236-45. PubMed ID: 19796273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evolution of induced pluripotent stem cell technology.
    Zhou H; Ding S
    Curr Opin Hematol; 2010 Jul; 17(4):276-80. PubMed ID: 20442654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Authentication and banking of human pluripotent stem cells.
    Josephson R; Auerbach J
    Curr Protoc Stem Cell Biol; 2009 Dec; Chapter 1():Unit 1C.9. PubMed ID: 19960451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proceedings: consideration of genetics in the design of induced pluripotent stem cell-based models of complex disease.
    Grieshammer U; Shepard KA
    Stem Cells Transl Med; 2014 Nov; 3(11):1253-8. PubMed ID: 25359995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Developing Induced Pluripotent Stem Cell-Based Therapy for the Masses.
    Rao MS; Atala A
    Stem Cells Transl Med; 2016 Feb; 5(2):129-31. PubMed ID: 26718646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.